Clover Health Investments (CLOV) Current Deferred Revenue (2022 - 2024)

Clover Health Investments has reported Current Deferred Revenue for 3 years, with the latest figure at $17000.0 in Q3 2024.

• For the quarter ending Q3 2024, Current Deferred Revenue fell 99.98% year-over-year to $17000.0; the trailing twelve-month figure through Sep 2024 stood at $17000.0 (down 99.98% YoY), and the FY2023 full-year result was $3.1 million, changed N/A from the prior year.
• Current Deferred Revenue for Q3 2024 stood at $17000.0, up from $13000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $113.5 million in Q2 2023, with the low at $13000.0 in Q2 2024.
• Historically, Current Deferred Revenue has averaged $60.6 million across 3 years, with a median of $96.4 million in 2022.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue advanced 7.2% — and 2024, when it slumped 99.99%.
• Clover Health Investments' Current Deferred Revenue stood at $96.4 million in 2022, then slumped by 96.78% to $3.1 million in 2023, then sank by 99.45% to $17000.0 in 2024.
• The last three Current Deferred Revenue figures came in at $17000.0 (Q3 2024), $13000.0 (Q2 2024), and $3.1 million (Q4 2023), per Business Quant data.